40 Hz Sound Therapy: What It Is, How It Works, and the Research Behind It

40 Hz sound therapy is a non-invasive approach to gamma entrainment — using precisely timed audio pulses at 40 cycles per second to drive measurable gamma-band neural activity. The published research behind it comes from MIT's Tsai Lab and is shaped into the well-known GENUS protocol (Gamma ENtrainment Using Sensory Stimuli). 40 Hz sound therapy has attracted sustained interest because the same gamma band is implicated in attention, memory, and several neurological and psychiatric conditions — most notably Alzheimer's disease, but also sleep, focus, anxiety, chronic pain, ADHD, and Parkinson's.

This article is a plain-language overview. For the full clinical reference — including the underlying evidence table, safety callouts, implementation details, and references — read the clinical one-pager on the GENUS protocol.

What is 40 Hz sound therapy?

40 Hz sound therapy is the practice of delivering audio stimuli at a steady 40 pulses per second — the center of the human brain's gamma band (roughly 30–100 Hz). When the brain's auditory cortex processes a regular 40 Hz pulse train, neural firing tends to lock onto that frequency, a phenomenon called auditory steady-state response (ASSR). The measurable neural response is large enough at 40 Hz to drive downstream changes in connected regions, which is why the frequency has become the focus of clinical-grade research.

Why the 40 Hz band specifically

Gamma oscillations (30–100 Hz) are tied to attention, working memory, conscious perception, and feature binding across sensory cortices. The 40 Hz sub-band is of particular clinical interest for two reasons. First, reduced gamma-band activity has been documented in neurodegenerative conditions — notably Alzheimer's disease, where the deficit is robust and reproducible. Second, 40 Hz is one of the few frequencies that produces a stable, measurable neural entrainment through pure external sensory stimuli (without invasive electrodes or pharmacology). That combination — pathological deficit plus non-invasive lever — is what made 40 Hz a clinical-research priority.

The science: gamma entrainment and the GENUS protocol

Gamma entrainment research crystallized around the GENUS protocol — short for Gamma ENtrainment Using Sensory Stimuli — developed in Li-Huei Tsai's lab at MIT's Picower Institute for Learning and Memory. GENUS is the cleanest, most-cited reference protocol in the field: precisely timed 40 Hz stimuli delivered through one or more sensory channels (light flicker, audio tones, haptic vibration), intended to recruit gamma oscillations across distributed brain networks. The full clinical reference, including the evidence table and implementation notes, lives on our clinical one-pager on the GENUS protocol.

Foundational papers

• Iaccarino et al. (2016) — Nature. The original GENUS paper. Visual-cortex 40 Hz flicker in Alzheimer's mouse models reduced amyloid load and modified microglia. This is the paper that put GENUS on the clinical map.
• Martorell et al. (2019) — Cell. Multisensory GENUS — combined auditory + visual 40 Hz produced stronger, more distributed gamma entrainment and greater reduction of Alzheimer's-associated pathology than either channel alone.
• Chan et al. (2021) — Alzheimer's & Dementia. A human study confirming that the 40 Hz auditory steady-state response is impaired in Alzheimer's disease patients — the human-pilot bridge from preclinical to clinical work.

Audio-only gamma entrainment has its own supporting literature, including work by Colzato et al. (2017) on 40 Hz auditory stimulation and Jirakittayakorn & Wongsawat (2017) on 40 Hz monaural / binaural beat effects — both cited in the clinical one-pager.

What 40 Hz sound therapy may help with

Published evidence and active research programs focus on a small set of indications where gamma-band dysregulation is a documented feature, or where rhythmic / multisensory stimulation has shown a reproducible effect. Each condition below is supported by a dedicated protocol page on Neurosonos, and the underlying clinical reference is on the clinical one-pager.

Alzheimer's disease & cognitive decline

The strongest preclinical signal for 40 Hz is in Alzheimer's disease and broader cognitive decline. Multisensory GENUS has been shown to reduce amyloid load and modify microglial response in mouse models, with human pilot work confirming the existence of a measurable 40 Hz auditory steady-state response in AD patients. Try the dedicated protocol at Neurosonos · Alzheimer's & Cognition therapy, and read the full clinical context on the clinical one-pager.

Sleep & insomnia

While 40 Hz itself is too fast to drive sleep, gamma-band activity is implicated in the pre-sleep transition and in dream-stage cortical processing. Auditory rhythmic stimulation is well-studied as a sleep-stage cue. The sleep protocol is available at Neurosonos · Sleep therapy; the full clinical background is on the one-pager.

Focus & ADHD

Attentional-state entrainment using beta-band (14–30 Hz) and 40 Hz visual + auditory cues has been studied in ADHD populations. Neurosonos's focus protocol is at Neurosonos · Focus therapy (and the ADHD-tuned variant at /therapy?condition=adhd). The clinical evidence trail is summarized on the one-pager.

Anxiety

Published alpha-entrainment (8–13 Hz) anxiety literature provides the main evidence base for anxiety-targeted sound therapy, but gamma-band auditory and visual stimulation are increasingly studied for acute-state anxiety reduction. Try the Neurosonos · Anxiety therapy protocol; the clinical reference sits on the one-pager.

Chronic pain

Pain-gate modulation literature supports rhythmic auditory stimulation as a non-pharmacological sensory intervention for chronic pain pathways. Neurosonos's pain protocol is at Neurosonos · Pain therapy, with the underlying evidence on the one-pager.

Parkinson's disease

Rhythmic Auditory Stimulation (RAS) at gait cadence is an established gait-rehabilitation technique for Parkinson's, and gamma-band stimulation is an area of active research. The Parkinson's-tuned protocol is available at Neurosonos · Parkinson's therapy, and the clinical context is summarized on the one-pager.

How to use 40 Hz sound therapy

The simplest way to use 40 Hz sound therapy today is to fire up a clinically-tuned protocol in Neurosonos. Pick the condition that fits — start with Alzheimer's & Cognition for the most-researched application — and the app delivers synchronized 40 Hz audio, light, and haptic stimulation. Headphones are strongly recommended; visual flicker requires full screen brightness; haptic works best with the phone resting against a flat surface.

For best results: a quiet room, headphones on, comfortable seated position, and a single 20–30 minute session. Two to three sessions per week is the typical published cadence for research-style use. The full implementation guide — including multisensory synchrony, headphone vs. speaker playback, and device setup — is on the clinical one-pager.

Safety & disclaimers

Photosensitive epilepsy. Anyone with photosensitive epilepsy, a history of seizures, or other neurological conditions should not use the visual flicker feature without explicit physician guidance. 40 Hz flickering light can trigger seizures in susceptible individuals. Please consult a neurologist before use.

No claims of clinical efficacy for any specific indication are made. The summary above references pre-clinical and early-stage human studies; clinical outcomes for individual patients are not established for any general-purpose 40 Hz gamma-entrainment software deployment. For the full safety and disclaimer language — including clinical-research references — see the clinical one-pager.